Madrigal Pharmaceuticals, Inc.
Ticker(s):
MDGL
Country:
Sector & Industry:
Business Overview
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Contact & Other Information
Number of Employees:
528
Website:
Four Tower Bridge
Suite 200 200 Barr Harbor Drive
West Conshohocken
,
PA
,
19428
United States
267 824 2827
No content was found.